About 70% of human cancers, including breast, bone, brain, B-cell lymphoma, colon, cervix, lung, pancreas, and prostate tumors have various MYC alterations that correlate with poor prognosis and increased disease aggressiveness [26,27]. The gene discussed is MYC; the disease is cancer.